Axonics Modulation Technologies (AXNX) intends to raise gross proceeds of $86.25 million from a U.S. IPO, according to an S-1 registration statement.The firm develops and commercializes minimally ...
Weighted-average shares used to compute basic and diluted net loss per share ...
IRVINE, Calif.--(BUSINESS WIRE)--Axonics, Inc. (Nasdaq: AXNX), a medical technology company that develops, manufactures and commercializes innovative and minimally invasive products to treat bladder ...
Boston Scientific Corporation plans to acquire Axonics, Inc. for $3.7 billion in cash to expand its urology offerings with Axonics' innovative urinary and bowel disorder treatments. Axonics, founded ...
Boston Scientific Corporation BSX recently closed the acquisition of Axonics, Inc., a medical technology company focused on the development and commercialization of differentiated devices to treat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback